Clinical, radiographic and patient-reported outcomes using MobiliT™ cup with ECiMa™ insert in primary total hip arthroplasty surgery.

Not Applicable

Recruiting

• Conditions: Osteoarthritis; Total Hip Arthroplasty; Musculoskeletal - Osteoarthritis; Surgery - Other surgery

• Registration Number: ACTRN12623000093684
• Lead Sponsor: Corin Australia Pty Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-01-27
• Last Update Posted: 22 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

The individual has signed a Patient Informed Consent Form (PICF), specific to this clinical investigation, and approved by the Human Research Ethics Committee.
- Both genders.
- Minimum age 18 years old, maximum age of 85 years old.
- The individual clinically qualifies for a dual mobility total hip arthroplasty surgery with MobiliT™ ECiMa cup and Paragon stem based on physical examination and medical history and has been scheduled for surgery.
- The individual is willing to comply with the required protocol for follow-up visits.

Exclusion Criteria

- Individuals under guardianship.
- Individuals with any physical or psychological condition which would impair clinical investigation participation.
- Individual with current hip infection.
- Any patient pregnant or with plans to become pregnant during the clinical study.
- Individuals who are already enrolled in other clinical studies.

Study & Design

• Study Type: Interventional
• Study Design: Not specified